Matching slides 78,138
Current window 63,541-63,570
Pages 2,605
Rows per page 30
Component: Chartclear collectionreset all

Component

63,541-63,570 of 78,138

filter-aware
10
Includes LTM 6/30/23 data and non-GAAP disclaimer.ModivCare | Investor Presentation Deck | 36 slides · ModivCare
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
17
ModivCare | Investor Presentation Deck | 36 slidesModivCare | Investor Presentation Deck | 36 slides · ModivCare
Pitch deck Investor relations Beat · Business ModelLoop · Quick Win Big Bet1 hit
20
The slide uses a mix of qualitative service descriptions and quantitative financial performance data.ModivCare | Investor Presentation Deck | 36 slides · ModivCare
Pitch deck Investor relations Beat · Business ModelLoop · Quick Win Big Bet1 hit
29
ModivCare | Investor Presentation Deck | 36 slidesModivCare | Investor Presentation Deck | 36 slides · ModivCare
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
07
The chart uses a standard waterfall bridge format to explain cash flow movements.ModivCare | Results Presentation Deck | 19 slides · ModivCare
Conference presentation Investor relations Beat · Evidence1 hit
08
The slide uses a waterfall bridge to reconcile cash from 2Q23 to YE23F.ModivCare | Results Presentation Deck | 19 slides · ModivCare
Conference presentation Investor relations Beat · Evidence1 hit
11
The bridge chart visualizes the impact of NEMT Volume, Trip Mix, and Contract Delays on the EBITDA guidance.ModivCare | Results Presentation Deck | 19 slides · ModivCare
Conference presentation Investor relations Beat · Evidence1 hit
05
Nano Dimension | Results Presentation Deck | 16 slidesNano Dimension | Results Presentation Deck | 16 slides · Nano Dimension
Conference presentation Investor relations Beat · InterestLoop · Logic Chain1 hit
07
The chart highlights Nano Dimension's superior performance relative to competitors who mostly experienced negative growth.Nano Dimension | Results Presentation Deck | 16 slides · Nano Dimension
Conference presentation Investor relations Beat · Desire1 hit
13
The chart illustrates the company's superior cash runway relative to operating cash burn compared to competitors.Nano Dimension | Results Presentation Deck | 16 slides · Nano Dimension
Conference presentation Investor relations Beat · Action1 hit
08
Uses a waterfall-style bridge to show market growth over time.Nano Dimension | Shareholder Engagement Presentation Deck | 34 slides · Nano Dimension
Shareholder letter Investor relations Beat · InterestLoop · Golden Circle1 hit
19
The chart compares specific acquisition multiples (Nano Dimension vs others) to demonstrate capital allocation discipline.Nano Dimension | Shareholder Engagement Presentation Deck | 34 slides · Nano Dimension
Shareholder letter Investor relations Beat · Desire1 hit
24
The slide uses a chevron-based process flow to illustrate the evolution of capital allocation strategy over time.Nano Dimension | Shareholder Engagement Presentation Deck | 34 slides · Nano Dimension
Shareholder letter Investor relations Beat · Action1 hit
31
Includes a legend for independent directors and committee chairs.Nano Dimension | Shareholder Engagement Presentation Deck | 34 slides · Nano Dimension
Shareholder letter Investor relations Beat · Action1 hit
32
The chart uses a visual representation of directors as blocks, with light blue for general directors and dark blue for independent directors.Nano Dimension | Shareholder Engagement Presentation Deck | 34 slides · Nano Dimension
Shareholder letter Investor relations Beat · Action1 hit
10
The chart illustrates a positive correlation between market penetration and user engagement.Nextdoor | Investor Presentation Deck | 34 slides · Nextdoor
Pitch deck Investor relations Beat · Traction1 hit
11
Nextdoor | Investor Presentation Deck | 34 slidesNextdoor | Investor Presentation Deck | 34 slides · Nextdoor
Pitch deck Investor relations Beat · Traction1 hit
12
The chart highlights Nextdoor in green, with other major platforms like Facebook, Snapchat, X, and Pinterest highlighted in their respective brand colors.Nextdoor | Investor Presentation Deck | 34 slides · Nextdoor
Pitch deck Investor relations Beat · Traction1 hit
14
The slide uses bubble charts to represent market size, with an arrow indicating growth.Nextdoor | Investor Presentation Deck | 34 slides · Nextdoor
Pitch deck Investor relations Beat · Traction1 hit
15
The chart uses area to represent total revenue potential (DAU * ARPU).Nextdoor | Investor Presentation Deck | 34 slides · Nextdoor
Pitch deck Investor relations Beat · Market SizeLoop · Cost Of Inaction1 hit
27
The chart uses stacked bars to show geographic segmentation of users over time.Nextdoor | Investor Presentation Deck | 34 slides · Nextdoor
Pitch deck Investor relations Beat · FinancialsLoop · Quick Win Big Bet1 hit
04
The slide uses a frequency spectrum diagram to visualize the specific band NextNav occupies.NextNav | Investor Presentation Deck | 10 slides · NextNav
Pitch deck Investor relations Beat · Problem1 hit
19
The chart displays dose-dependent exposure levels exceeding multiple efficacy targets (ROS1 G2032R and Wild Type in CNS and periphery).Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations Beat · TractionLoop · Day In Life1 hit
21
The chart uses a waterfall plot to visualize clinical efficacy, a standard in oncology drug development.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations Beat · TractionLoop · Day In Life1 hit
22
The chart is a swimmer plot (a common clinical trial visualization).Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations Beat · TractionLoop · Day In Life1 hit
10
Includes a patient-derived xenograft (PDX) study workflow diagram and a tumor volume growth curve.Nuvectis Pharma | Investor Presentation Deck | 23 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
11
The chart shows tumor volume reduction over 28 days compared to vehicle control.Nuvectis Pharma | Investor Presentation Deck | 23 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
12
Clinical trial NCT05226507 status update.Nuvectis Pharma | Investor Presentation Deck | 23 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
17
Includes a biological pathway diagram, microscopy images, and an IC50 dose-response curve.Nuvectis Pharma | Investor Presentation Deck | 23 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
16
The chart is a Kaplan-Meier survival curve showing the impact of fluid overload on patient outcomes.Nuwellis | Investor Presentation Deck | 29 slides · Nuwellis
Pitch deck Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit